Changing smoking patterns and mortality from chronic obstructive pulmonary disease

Preventive Medicine

Volumn 26, Issue 4, 1997, Pages 418-421

  Wise, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gender; Mortality; Obstructive lung diseases; Race; Smoking

Indexed keywords

AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING;

EID: 0031194340     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1997.0181     Document Type: Article

References (23)

1. Snider G L. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Annu Rev Med. 40:1989;411-429.
2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1:1977;1645-1648.
3. Burrows B, Knudson R J, Camilli A E, Lyle S K, Lebowitz M D. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis. 135:1987;788-793.
4. Peto R, Speizer F E, Cochrane A L, Moore F, Fletcher C M, Tinker C M. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation. Am Rev Respir Dis. 128:1983;491-500.
5. Manfreda J, Mao Y, Litven W. Morbidity and mortality from chronic obstructive pulmonary disease. Am Rev Respir Dis. 140:1989;S19-S28.
6. Burrows B, Bloom J W, Trayer G A, Cline M G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 317:1987;1309-1314.
7. Beaty T H, Menkes H A, Cohen B H, Newill C A. Risk factors associated with longitudinal change in pulmonary function. Am Rev Respir Dis. 129:1984;660-667.
8. Higgins M. Risk factors associated with chronic obstructive lung diseases. Ann NY Acad Sci. 624:1991;7-17.
9. O'Connor G T, Sparrow D, Weiss St. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. State of the art review. Am Rev Respir Dis. 140:1989;225-252.
10. Fletcher C, Peto R, Tinker C, Speizer F E. The natural history of chronic bronchitis and emphysema. 1976;Oxford Univ Press, New York.
11. Xu X, Dockery D W, Ware J H, Speizer F E, Ferris B G. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis. 146:1992;1345-1346.
12. Anthonisen N R, Connett J E, Kiley J P, Altose M D, Bailey W C, Buist A S, Conway W A Jr, Enright P L, Kanner R E, O'Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. JAMA. 272:1994;1497-1505.
13. Kanner R E, Connett J E, Altose M D, Buist A S, Lee W W, Tashkin D P, Wise R A. Gender difference in airway hyperreponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med. 150:1994;956-961.
14. Gillum R F. Chronic obstructive pulmonary disease in blacks and whites: mortality and morbidity. J Natl Med Assoc. 82:1990;417-428.
15. NIH-NHLBI, 1994, Morbidity and mortality, U.S. Govt. Printing Office.
16. National Center for Health Statistics, 1991, Vital statistics of the United States, II, U.S. Govt. Printing Office, Public Health Service, Washington.
17. A, J, Klebba, 1982, Mortality from diseases associated with smoking, United States, 1960-1977, National Center for Health Statistics, U.S. Govt. Printing Office, Washington.
18. Burrows B. The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago "COPD" series. Am Rev Respir Dis. 140:1989;S92-S94.
19. Terho E O, Koskenvuo M, Kaprio J. Atopy: a predisposing factor for chronic bronchitis in Finland. J Epidemiol Community Health. 49:1995;296-298.
20. Sluiter H J, Keoter G H, de Monchy J G, Postma D S, de Vries K, Orie N G. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J. 4:1991;479-489.
21. Tashkin D P, Altose M D, Connett J E, Kanner R E, Lee W W, Wise R A. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 153:1996;1802-1811.
22. Weiss K B, Gergen P J, Crain E F. Inner-city asthma. The epidemiology of an emerging US public health concern. Chest. 101:1992;362S-367S.
23. U.S. Department of Health and Human Services, 1988, The Health Consequences of Smoking; Nicotine Addiction. A Report of the Surgeon General, 563, 587.